SCRIP Intelligence is the leading source of news and strategic analysis for the global pharmaceutical industry. We filter the flood of information on the industry and apply the knowledge of our extensive network of analysts, journalists and key opinion leaders to provide our readers with timely business-critical market and competitor intelligence.
Our experienced writers and analysts are based in key geographic markets and cover all aspects of the industry – from small biotech start-ups to multinational giants, research boutiques to generic manufacturers. We focus on the whole of the drug discovery and development value chain and report on regulatory news, product approvals and rejections, and key corporate events.
In addition to our internal resources, SCRIP Intelligence reaches out to expert colleagues in other Informa businesses including Datamonitor, Citeline, Scrip Business Insights, Scrip Regulatory Affairs, Clinica and the Informa Healthcare journals. Owing to our high standing within the industry and the credibility of our writers, SCRIP Intelligence also enjoys privileged access to the industry's key thinkers and opinion leaders.